Cargando…

The promise of anti-angiogenic cancer therapy

Detalles Bibliográficos
Autores principales:	Oehler, M K, Bicknell, R
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374416/ https://www.ncbi.nlm.nih.gov/pubmed/10732738 http://dx.doi.org/10.1054/bjoc.1999.0991

Ejemplares similares

Imatinib may be ABL to improve anti-angiogenic therapy
por: Raimondi, Claudio, et al.
Publicado: (2015)

Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics
por: Abdalla, Ahmed M.E., et al.
Publicado: (2018)

Revisiting anti-angiogenic therapy for recurrent glioblastoma
por: Peters, Katherine B.
Publicado: (2019)

The Promising Role of New Generation HDACis in Anti-Cancer Therapies
por: Hervouet, Eric
Publicado: (2018)

Tamoxifen induction of angiogenic factor expression in endometrium
por: Hague, S, et al.
Publicado: (2002)

Structured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma
por: Castelli, Chiara, et al.
Publicado: (2013)

Anti-angiogenic alternatives to VEGF blockade
por: Khan, Kabir A., et al.
Publicado: (2015)

Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer
por: Oehler, M K, et al.
Publicado: (2003)

Angiogenic signaling pathways and anti-angiogenic therapy for cancer
por: Liu, Zhen-Ling, et al.
Publicado: (2023)

A Combinatorial Investigation of the Response to Anti-angiogenic Therapy in Breast Cancer: New Strategies for Patient Selection and Opportunities for Reconsidering Anti-VEGF, Anti-PI3K and Checkpoint Inhibition
por: Labanca, Valentina, et al.
Publicado: (2016)

Deregulation of the circadian clock machinery: A novel biomarker for anti-angiogenic drug resistance in colorectal cancer
por: Della-Morte, David
Publicado: (2019)

Pancreatic Cancer: Targeted Therapy Holds the Promise
por: Zhou, Zhijun, et al.
Publicado: (2021)

Biomarkers for Anti-Angiogenic Therapy in Cancer
por: Wehland, Markus, et al.
Publicado: (2013)

Anti-angiogenic therapy for ovarian cancer
por: García García, Yolanda, et al.
Publicado: (2020)

Using proteomimetics to switch angiogenic signaling
por: Teng, Peng, et al.
Publicado: (2022)

Recent Advances in Anti-Angiogenic Therapy of Cancer
por: Samant, Rajeev S., et al.
Publicado: (2011)

Future options of anti-angiogenic cancer therapy
por: Cao, Yihai
Publicado: (2016)

Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer
por: Nienhüser, Henrik, et al.
Publicado: (2017)

Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers
por: Olejarz, Wioletta, et al.
Publicado: (2020)

Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
por: Haibe, Yolla, et al.
Publicado: (2020)

Nephrotoxicity of Anti-Angiogenic Therapies
por: Van Wynsberghe, Margaux, et al.
Publicado: (2021)

Anti-angiogenic therapies in the management of glioblastoma
por: Schulte, Jessica D., et al.
Publicado: (2021)

Induction of thrombospondin-1 partially mediates the anti-angiogenic activity of dexrazoxane
por: Maloney, S L, et al.
Publicado: (2009)

The promise and pitfalls of the internet for cognitive behavioral therapy
por: Andersson, Gerhard
Publicado: (2010)

Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
por: Song, Yuxiao, et al.
Publicado: (2020)

Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies
por: Comunanza, Valentina, et al.
Publicado: (2017)

Anti-angiogenic therapies for advanced esophago-gastric cancer
por: Fontana, Elisa, et al.
Publicado: (2014)

Tumor angiogenesis and anti-angiogenic gene therapy for cancer
por: Li, Tinglu, et al.
Publicado: (2018)

Anti-angiogenic therapies in brain metastases
por: Berghoff, Anna S., et al.
Publicado: (2018)

Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway
por: Itatani, Yoshiro, et al.
Publicado: (2018)

Promise of cancer stem cell vaccine
por: Zhou, Li, et al.
Publicado: (2015)

Lipidomics: a promising cancer biomarker
por: Yan, Furong, et al.
Publicado: (2018)

Commentary: Understanding angiogenic factors in pathogenesis of persistent fetal vasculature
por: Khokhar, Sudarshan, et al.
Publicado: (2019)

CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
por: Dai, Wei-Jing, et al.
Publicado: (2016)

Pruritis: A Vexing Problem With a Promising New Therapy
por: Wetmore, James B.
Publicado: (2020)

Low-Dose Radiation Therapy for COVID-19: Promises and Pitfalls
por: Venkatesulu, Bhanu P, et al.
Publicado: (2020)

Structure Activity Relationship of Key Heterocyclic Anti-Angiogenic Leads of Promising Potential in the Fight against Cancer
por: Nada, Hossam, et al.
Publicado: (2021)

Left bundle branch pacing: a promising modality for cardiac resynchronisation therapy
por: Luermans, Justin G. L. M., et al.
Publicado: (2023)

Optimization of Ultrasound-mediated Anti-angiogenic Cancer Gene Therapy
por: Fujii, Hiroko, et al.
Publicado: (2013)

Anti-angiogenic peptides application in cancer therapy; a review
por: Shoari, Alireza, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6j1gq2e0oqs646as1fu8rvr088